We therefore selected four patient-derived xenograft (PDX) models of breast cancer (BRPF212, BRPF280, BRPF232, and BRPF008) (Fig. S2) to analyze the changes in KIFC1 protein levels after treatment with conventional chemotherapeutic drugs including cisplatin and etoposide. Here, KIFC1 is linked to breast carcinoma.